18,950 Shares in Corteva, Inc. $CTVA Purchased by Meeder Advisory Services Inc.

Meeder Advisory Services Inc. purchased a new stake in shares of Corteva, Inc. (NYSE:CTVA) during the second quarter, HoldingsChannel.com reports. The firm purchased 18,950 shares of the company’s stock, valued at approximately $1,605,000.

A number of other hedge funds and other institutional investors have also bought and sold shares of CTVA. JPL Wealth Management LLC purchased a new stake in Corteva in the 3rd quarter worth approximately $25,000. Garton & Associates Financial Advisors LLC purchased a new position in shares of Corteva during the fourth quarter valued at approximately $27,000. Bank of Jackson Hole Trust purchased a new stake in Corteva in the fourth quarter worth $28,000. Cornerstone Financial Management LLC bought a new stake in Corteva in the fourth quarter valued at $29,000. Finally, Elevation Wealth Partners LLC boosted its holdings in Corteva by 334.6% in the second quarter. Elevation Wealth Partners LLC now owns 339 shares of the company’s stock valued at $29,000 after acquiring an additional 261 shares in the last quarter. Institutional investors own 81.54% of the company’s stock.

Corteva Stock Performance

Shares of CTVA stock opened at $78.51 on Thursday. The company’s fifty day moving average price is $81.92 and its 200-day moving average price is $80.15. The stock has a market cap of $52.38 billion, a PE ratio of 51.99, a price-to-earnings-growth ratio of 2.39 and a beta of 0.57. The company has a current ratio of 1.52, a quick ratio of 1.10 and a debt-to-equity ratio of 0.07. Corteva, Inc. has a 12 month low of $60.53 and a 12 month high of $90.97.

Corteva (NYSE:CTVA) last issued its quarterly earnings results on Thursday, July 30th. The company reported $2.30 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.24 by $0.06. Corteva had a net margin of 5.66% and a return on equity of 10.18%. The company had revenue of $6.38 billion during the quarter, compared to analyst estimates of $6.60 billion. During the same period last year, the business earned $2.20 EPS. Corteva’s quarterly revenue was down 1.2% compared to the same quarter last year. Corteva has set its FY 2026 guidance at 3.600-3.800 EPS. On average, equities analysts expect that Corteva, Inc. will post 3.72 EPS for the current fiscal year.

Corteva Announces Dividend

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, September 15th. Shareholders of record on Tuesday, September 1st will be paid a dividend of $0.18 per share. The ex-dividend date of this dividend is Tuesday, September 1st. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.9%. Corteva’s dividend payout ratio (DPR) is currently 47.68%.

Wall Street Analyst Weigh In

CTVA has been the subject of several research reports. Rothschild & Co Redburn upped their price objective on shares of Corteva from $80.00 to $90.00 and gave the stock a “neutral” rating in a report on Wednesday, April 29th. Barclays boosted their price target on shares of Corteva from $84.00 to $91.00 and gave the company an “overweight” rating in a research report on Thursday, June 11th. Oppenheimer increased their price target on shares of Corteva from $89.00 to $95.00 and gave the stock an “outperform” rating in a research note on Thursday, July 23rd. Morgan Stanley lifted their price objective on Corteva from $84.00 to $95.00 and gave the company an “overweight” rating in a research report on Thursday, May 28th. Finally, Zacks Research downgraded Corteva from a “strong-buy” rating to a “hold” rating in a report on Tuesday, August 11th. Fourteen analysts have rated the stock with a Buy rating and nine have assigned a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $91.50.

Corteva Company Profile

Corteva, Inc (NYSE: CTVA) is an independent global agriculture company that was established as a publicly traded firm in mid?2019 following the separation of the agriculture businesses from DowDuPont. The company focuses on delivering technologies and products that help farmers increase productivity and manage crop health. Corteva’s operations combine seed genetics, crop protection chemistries, digital tools and biological solutions to address the full cycle of crop production.

Core business activities include research and development of seed genetics and trait technologies, formulation and sale of crop protection products (such as herbicides, insecticides and fungicides), and the development of seed treatments and biologicals.